Joshua Aggson, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3720 Church Rock St, Gallup, NM 87301 Phone: 505-722-2261 |
Holly Ann Knox, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 345 Basileo Dr, Gallup, NM 87301 Phone: 505-721-1800 Fax: 505-721-1899 |
Mrs. Beth Karol Marotta, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 S Boardman Ave, Gallup, NM 87301 Phone: 505-721-1011 |
Dianne Louise Conkling, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Aztec Ave, Gallup, NM 87301 Phone: 505-721-1845 |
Anjelika Vasquez, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Aztec Ave, Gallup, NM 87301 Phone: 505-722-4101 |
Virginia L Beamsley, M.S.,CCC-SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1010 Milda St, Gallup, NM 87301 Phone: 505-722-2844 Fax: 505-863-3964 |
News Archive
Federal officials have said that Medicare's controversial new drug benefit for seniors, may in fact cost less than first projected, because of the very competitive bids from insurers and other providers.
Company IberoGEN at the Miguel Hernández University of Elche (UMH) has developed a test for the early detection of coronavirus on surfaces susceptible to contamination from everyday use, such as handles, railings, switches, telephones, and keyboards, which is intended for comprehensive service companies as well as specialised entities.
A study led by researchers at the University of Southampton, UK, has identified a novel short isoform of the full-length receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses to gain entry to host cells.
Researchers at Boston College, MA, have found that reducing calorie intake can restrict the growth and spread of brain cancer. Writing in ASN NEURO, Laura Shelton and colleagues report success with mice suffering from glioblastoma multiforme, the most aggressive and invasive form of primary human brain cancer.
Fractyl Laboratories Inc. (Fractyl) announced today publication of data in the current issue of Diabetes Care from the Company's first-in-human study of RevitaTM duodenal mucosal resurfacing (Revita DMR).
› Verified 7 days ago